Lipoprotein (a) and apolipoprotein (a) in primary antiphospholipid syndrome

Clinical Biochemistry

Volumn 40, Issue 5-6, 2007, Pages 317-320

  Bećarević, Mirjana ^a,b   Singh, Sandra ^a   Majkić Singh, Nada ^a,c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c Institute of Medical Biochemistry

Author keywords

Apolipoprotein (a); Cerebrovascular insults; Lipoprotein (a); Myocardial infarctions; Primary antiphospholipid syndrome

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; APOLIPOPROTEINS A; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED;

EID: 33847316646     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.11.018     Document Type: Article

References (17)

1. Hughes G.R.V. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br. Med. J. 287 (1983) 1088-1089
2. Marcovina S., and Koschinsky M. Lipoprotein (a): structure, measurement and clinical significance. In: Rifai N., Warnick R., and Dominizcak M. (Eds). Handbook of lipoprotein testing (2000), AACC Press, Washington, DC 345-386
3. Jimnnez S., Garcia-Criado M.A., Tassies D., et al. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 44 6 (2005) 756-761
4. Kiss E., Fazekas B., Tarr T., et al. Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein (a) in lupus nephritis. Hung Med. J. 145 (2004) 217-222
5. Romero F.I., Khamashta M.A., and Hughes G.R.V. Lipoprotein (a) oxidation and autoantibodies: a new path in atherothrombosis. Lupus 9 (2000) 206-209
6. Atsumi T., Khamashta M.A., Andujar C., et al. Elevated plasma lipoprotein (a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. J. Rheumatol. 25 1 (1998) 69-73
7. Yamazaki M., Asakura H., Jokaji H., et al. Plasma levels of lipoprotein (a) are elevated in patients with the antiphospholipid antibody syndrome. Thromb. Haemost. 71 4 (1994) 424-427
8. Wilson W.A., Gharavi A.E., Koike T., et al. International statement on preliminary classification criteria for definite antiphospholipid symdrome. Report of an International Workshop. Arthritis Rheum. 42 7 (1999) 1309-1311
9. Miyakis S., Lockshin M., Atsumi T., et al. International consensus statement on an update of the classification criteria for the definite antiphospholipid syndrome. J. Throm. Haemostasis 4 2 (2006) 295-306
10. Brandt J.T., Triplett D.A., Alving B., and Scharrer J. Criteria for the diagnosis of lupus anticoagulants: an update on behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipd Antibody of the Scientific and Standardisation Committee of the International Society of Thrombosis and Haemostasis. Thromb. Haemost. 74 4 (1995) 1185-1190
11. Friedwald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol without the use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499
12. Cantin B., Gagnon F., Moorjani S., et al. Is lipoprotein (a) an independent risk factor for ischemic heart disease in men? The Quebec cardiovascular study. J. Am. Coll. Cardiol. 31 (1998) 519-525
13. Goldstein L.B., Adams R., and Becker K. Primary prevention of ischemic stroke. A statement for healthcare professionals from the stroke council of the American heart association. Stroke 32 (2001) 280-299
14. Calmarza P., Cordero J., Santos V., and Vella J.C. Apolipoprotein (a) isoforms in infarcted men under 60 years old. Clin. Biochem. 37 (2004) 911-918
15. Kronenberg F., Kronenberg M.F., Kiechl S., et al. Role of lipoprotein (a) and apolipoprotein (a) phenotype in atherogenesis: prospective results from the Bruneck Study. Circulation 100 (1999) 1154-1160
16. Gromnica-Ihle E., and Schõsler W. Antiphospholipid syndrome. Int. Arch. Allergy Immunol. 123 (2000) 67-76
17. Sanna G., Bertolaccini M.L., Cuadrado M.J., Khamashta M.A., and Hughes G.R.V. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology 42 (2003) 200-213